TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 29424676

Group type: EXPERIMENTAL
Intervention: Condoliase 1.25 U
Number of subjects: 194

Group type: EXPERIMENTAL
Intervention: Condoliase 2.5 U
Number of subjects: 194

Group type: EXPERIMENTAL
Intervention: Condoliase 5 U
Number of subjects: 194

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 194

Group type: EXPERIMENTAL
Intervention: All condoliase groups
Number of subjects: 194

Group type: EXPERIMENTAL
Intervention: Condoliase groups
Number of subjects: 194
Study: 27302721

Group type: EXPERIMENTAL
Intervention: Problem-solving therapy (PST) provided by a bilingual social worker
Number of subjects: 387

Group type: EXPERIMENTAL
Intervention: Depression remission (measured with Patient Health Questionnaire-9 and Hopkins Symptom Checklist-20)
Number of subjects: 387
Study: 24843974

Group type: EXPERIMENTAL
Intervention: Electroacupuncture at Changqiang (GV 1) and Chengshan (BL 57) 30 min before surgery
Number of subjects: 120

Group type: COMPARATOR
Intervention: Sham electroacupuncture (shallow needling without electrical stimulation at a sham acupoint) 30 min before surgery
Number of subjects: 120

Group type: COMPARATOR
Intervention: Blank group (no treatment before surgery)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Electroacupuncture group
Number of subjects: 120

Group type: COMPARATOR
Intervention: Sham electroacupuncture group
Number of subjects: 120

Group type: COMPARATOR
Intervention: Blank group
Number of subjects: 120
Study: 22592900

Group type: EXPERIMENTAL
Intervention: Off-pump CABG
Number of subjects: 2203

Group type: COMPARATOR
Intervention: Ineffective revascularization
Number of subjects: 2203
Study: 20543219

Group type: EXPERIMENTAL
Intervention: Weighted-jump-rope training (n = 9)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Unweighted-jump-rope training (n = 8)
Number of subjects: 24

Group type: COMPARATOR
Intervention: No specific training program (n = 7)
Number of subjects: 24
Study: 19014834

Group type: EXPERIMENTAL
Intervention: Valsartan 160 mg + Simvastatin 40 mg
Number of subjects: 872

Group type: COMPARATOR
Intervention: Valsartan 160 mg + Simvastatin 20 mg
Number of subjects: 872

Group type: EXPERIMENTAL
Intervention: Valsartan 320 mg + Simvastatin 40 mg
Number of subjects: 872

Group type: COMPARATOR
Intervention: Valsartan 320 mg + Simvastatin 20 mg
Number of subjects: 872

Group type: EXPERIMENTAL
Intervention: Valsartan 160/320 mg + Simvastatin 20 mg
Number of subjects: 872

Group type: EXPERIMENTAL
Intervention: Valsartan 160/320 mg + Simvastatin 40 mg
Number of subjects: 872
Study: 16898379

Group type: EXPERIMENTAL
Intervention: Alternative therapy failure criteria
Number of subjects: 876

Group type: COMPARATOR
Intervention: WHO therapy failure criteria
Number of subjects: 876
Study: 12814907

Group type: EXPERIMENTAL
Intervention: Needle acupuncture
Number of subjects: 48

Group type: COMPARATOR
Intervention: Sham laser stimulation
Number of subjects: 48

Group type: COMPARATOR
Intervention: Laser acupuncture
Number of subjects: 48
Study: 11185634

Group type: EXPERIMENTAL
Intervention: Oral telmisartan 20 mg
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Oral telmisartan 120 mg
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Intravenous telmisartan 120 mg
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Oral and i.v. telmisartan
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Oral telmisartan
Number of subjects: 24
Study: 8858631

Group type: EXPERIMENTAL
Intervention: Subconjunctival mitomycin-C (MMC) administration (0.27 mg/ml for 5 minutes)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Intrascleral mitomycin-C (MMC) administration (0.27 mg/ml for 5 minutes)
Number of subjects: 23
Study: 1298601

Group type: EXPERIMENTAL
Intervention: Selenium yeast 200 g Se1Tab/day
Number of subjects: 4065

Group type: COMPARATOR
Intervention: Common yeast 1 Tab/day
Number of subjects: 4065
Study: 6387672

Group type: EXPERIMENTAL
Intervention: Cornstarch powder
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Talcum powder
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (no powder)
Number of subjects: 0
Study: 29466081

Group type: EXPERIMENTAL
Intervention: Kinesio tape
Number of subjects: 141

Group type: COMPARATOR
Intervention: Sham tape
Number of subjects: 141

Group type: COMPARATOR
Intervention: No tape
Number of subjects: 141
Study: 29608685

Group type: EXPERIMENTAL
Intervention: Dolutegravir/lamivudine
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Dolutegravir monotherapy
Number of subjects: 91

Group type: COMPARATOR
Intervention: Triple therapy (control arm)
Number of subjects: 91
Study: 26869191

Group type: EXPERIMENTAL
Intervention: Omarigliptin (50 mg, once weekly for 4 weeks)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study: 25041101

Group type: EXPERIMENTAL
Intervention: Farman entrainer and pediatric t-piece
Number of subjects: 60

Group type: COMPARATOR
Intervention: Pediatric drawover apparatus
Number of subjects: 60
Study: 22273781

Group type: EXPERIMENTAL
Intervention: Double-bundle ACL reconstruction
Number of subjects: 42

Group type: COMPARATOR
Intervention: Single-bundle ACL reconstruction
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Both groups (SB and DB)
Number of subjects: 42
Study: 19962297

Group type: EXPERIMENTAL
Intervention: Mediterranean Diet supplemented with nuts
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Mediterranean Diet supplemented with virgin olive oil
Number of subjects: 50

Group type: COMPARATOR
Intervention: Low-fat diet
Number of subjects: 50
Study: 18607246

Group type: EXPERIMENTAL
Intervention: Active smoking
Number of subjects: 140

Group type: COMPARATOR
Intervention: Nonactive smoking
Number of subjects: 140
Study: 15809885

Group type: EXPERIMENTAL
Intervention: Deferiprone 75 mg/kg daily for 12 months
Number of subjects: 15
Study: 12034649

Group type: EXPERIMENTAL
Intervention: Obstructive sleep apnea patients
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control subjects
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Obstructive sleep apnea severity
Number of subjects: 22
Study: 10463519

Group type: EXPERIMENTAL
Intervention: ondansetron 8 mg
Number of subjects: 2574

Group type: EXPERIMENTAL
Intervention: ondansetron 16 mg
Number of subjects: 2574

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 2574
Study: 7836086

Group type: EXPERIMENTAL
Intervention: S + RT (surgery plus radiotherapy)
Number of subjects: 80

Group type: COMPARATOR
Intervention: S (surgery) alone
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Overall survival
Number of subjects: 80
Study: 2239759

Group type: EXPERIMENTAL
Intervention: Medium-chain triglycerides (MCT) diet for 6 days
Number of subjects: 0

Group type: COMPARATOR
Intervention: Long-chain triglycerides (LCT) diet for 6 days
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Medium-chain triglycerides (MCT) diet
Number of subjects: 0
Study: 329741

Group type: EXPERIMENTAL
Intervention: Cyclophosphamide as a single agent
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Actinomycin D‐‐vincristine combination
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Cyclophosphamide‐‐methotrexate‐‐vincristine combination
Number of subjects: 100
Study: 30282520

Group type: EXPERIMENTAL
Intervention: Flexible sigmoidoscopy (FS) screening
Number of subjects: 44041
Study: 28768788

Group type: EXPERIMENTAL
Intervention: Plate fixation
Number of subjects: 123

Group type: COMPARATOR
Intervention: Elastic stable intramedullary nailing (ESIN)
Number of subjects: 123
Study: 24943362

Group type: EXPERIMENTAL
Intervention: ECT group
Number of subjects: 158

Group type: EXPERIMENTAL
Intervention: Video group
Number of subjects: 158

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 158
Study: 23731234

Group type: EXPERIMENTAL
Intervention: Ankaferd Blood Stopper (ABS)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control (regular tubeless PCNL)
Number of subjects: 90
Study: 21570345

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 380
Study: 18988277

Group type: EXPERIMENTAL
Intervention: Bioactive glass S53P4 (BG)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Autogenous bone (AB)
Number of subjects: 25
Study: 16566622

Group type: EXPERIMENTAL
Intervention: Imipramine (209 mg/day, SD: 91.7, range: 75-325 mg/day)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study: 15038944

Group type: EXPERIMENTAL
Intervention: Sumatriptan 50 mg
Number of subjects: 432

Group type: EXPERIMENTAL
Intervention: Sumatriptan 100 mg
Number of subjects: 432

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 432
Study: 11159266

Group type: EXPERIMENTAL
Intervention: Bilateral auricular acupuncture at the 'relaxation' point
Number of subjects: 55

Group type: COMPARATOR
Intervention: Bilateral auricular acupuncture at the 'shenmen' point
Number of subjects: 55

Group type: COMPARATOR
Intervention: Bilateral auricular acupuncture at a 'sham' point
Number of subjects: 55
Study: 9777685

Group type: EXPERIMENTAL
Intervention: Immunochemotherapy as an adjuvant treatment after curative resection of gastric cancer
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 7792331

Group type: EXPERIMENTAL
Intervention: Clinical criteria
Number of subjects: 88

Group type: COMPARATOR
Intervention: Research criteria
Number of subjects: 88
Study: 3344781

Group type: EXPERIMENTAL
Intervention: Posterior chamber lenses with intracapsular fixation
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Anterior chamber lenses with posterior capsule left intact
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Anterior chamber lenses with ruptured posterior capsule
Number of subjects: 37
Study: 30981943

Group type: EXPERIMENTAL
Intervention: Caregiver assisted home-based cognitive remediation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Clinic-based cognitive remediation
Number of subjects: 0
Study: 28197749

Group type: EXPERIMENTAL
Intervention: Lifestyle-based training (two weekly group sessions lasting 60-90 minutes)
Number of subjects: 126
Study: 26164666

Group type: EXPERIMENTAL
Intervention: 2-L PEG plus bisacodyl
Number of subjects: 211

Group type: COMPARATOR
Intervention: 4-L PEG
Number of subjects: 211
Study: 23590671

Group type: EXPERIMENTAL
Intervention: Deferasirox therapy
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control (no deferasirox therapy)
Number of subjects: 16
Study: 21943026

Group type: EXPERIMENTAL
Intervention: In-country testing using two HIV rapid tests
Number of subjects: 2247

Group type: EXPERIMENTAL
Intervention: HIV prevalence by location
Number of subjects: 2247
Study: 19044228

Group type: EXPERIMENTAL
Intervention: SCHWIND ESIRIS laser
Number of subjects: 22

Group type: COMPARATOR
Intervention: WaveLight ALLEGRETTO WAVE Eye‐Q laser
Number of subjects: 22
Study: 16945637

Group type: EXPERIMENTAL
Intervention: Direct vision urethrotomy alone
Number of subjects: 72

Group type: COMPARATOR
Intervention: Direct vision urethrotomy plus clean intermittent catheterization for 3 months
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Direct vision urethrotomy following tubularized graft urethroplasty
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Direct vision urethrotomy following tubularized island flap urethroplasty
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Direct vision urethrotomy following onlay flap urethroplasty
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Direct vision urethrotomy following urethral plate urethroplasty
Number of subjects: 72
Study: 12417966

Group type: EXPERIMENTAL
Intervention: 100 mg modafinil
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 200 mg modafinil
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 10868020

Group type: EXPERIMENTAL
Intervention: Intra-articular injection of Triamcinolonhexacetonide
Number of subjects: 0

Group type: COMPARATOR
Intervention: NSAID plus physiotherapy
Number of subjects: 0
Study: 9160484

Group type: EXPERIMENTAL
Intervention: Mixed effects Poisson regression model for recurrent event data
Number of subjects: 0
Study: 8438948

Group type: EXPERIMENTAL
Intervention: 1 gm of ampicillin intravenously
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: 1 gm of ampicillin plus 0.5 gm of sulbactam intravenously
Number of subjects: 22
Study: 3530031

Group type: EXPERIMENTAL
Intervention: Simple instructions for the use of spacer aerosols
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Complicated manufacturer's instructions
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study: 30440834

Group type: EXPERIMENTAL
Intervention: Active tDCS
Number of subjects: 10

Group type: COMPARATOR
Intervention: Sham
Number of subjects: 10
Study: 27281799

Group type: EXPERIMENTAL
Intervention: Immediate-release arginine (IR-Arg) 1.5 g, 3 times/day
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Sustained-release arginine (SR-Arg) 1.5 g, 3 times/day
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Sustained-release arginine (SR-Arg) in HTW subjects
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Immediate-release arginine (IR-Arg) in HTW subjects
Number of subjects: 27

Group type: COMPARATOR
Intervention: Sustained-release arginine (SR-Arg) in CON subjects
Number of subjects: 27
Study: 25749641

Group type: EXPERIMENTAL
Intervention: Moderate intensity exercise
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Low intensity exercise
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Vigorous intensity exercise
Number of subjects: 14

Group type: COMPARATOR
Intervention: Albuterol
Number of subjects: 14
Study: 23860204

Group type: EXPERIMENTAL
Intervention: Epoetin alfa
Number of subjects: 1284

Group type: COMPARATOR
Intervention: Control (non-ESA)
Number of subjects: 1284
Study: 20530222

Group type: EXPERIMENTAL
Intervention: CYP2D6*10/*10 (intermediate metabolizer)
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: CYP2D6*4/*4 (poor metabolizer)
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: CYP2D6*5/*10 (intermediate metabolizer)
Number of subjects: 108

Group type: COMPARATOR
Intervention: CYP2D6*1/*1 (extensive metabolizer)
Number of subjects: 108
Study: 18795388

Group type: EXPERIMENTAL
Intervention: Immediate exercise group (IEG; n = 30)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Delayed exercise group (DEG; n = 30)
Number of subjects: 60
Study: 15367433

Group type: EXPERIMENTAL
Intervention: Reduced-intensity conditioning regimen
Number of subjects: 33

Group type: COMPARATOR
Intervention: Myeloablative conditioning
Number of subjects: 33
Study: 12438559

Group type: COMPARATOR
Intervention: ISIS 104838 (20‐mer phosphorothioate antisense oligonucleotide) administered intravenously (i.v.) at doses of 0.1-6 mg/kg
Number of subjects: 0

Group type: COMPARATOR
Intervention: ISIS 104838 (20‐mer phosphorothioate antisense oligonucleotide) administered intravenously (i.v.)
Number of subjects: 0

Group type: COMPARATOR
Intervention: ISIS 104838 (20‐mer phosphorothioate antisense oligonucleotide) administered subcutaneously (s.c.)
Number of subjects: 0
Study: 10602961

Group type: EXPERIMENTAL
Intervention: Double-contrast pharyngography (DCP)
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: Double-contrast pharyngography (DCP) and indirect laryngoscopy (IL) together
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: Computed Tomography (CT)
Number of subjects: 151
Study: 7562881

Group type: EXPERIMENTAL
Intervention: Slow-release nifedipine 20 mg twice daily for 4 weeks
Number of subjects: 0
Study: 1710802

Group type: EXPERIMENTAL
Intervention: Carbimazole (antithyroid drug) for 18 months
Number of subjects: 2

Group type: COMPARATOR
Intervention: Antithyroid drug for 6 months
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Antithyroid drug for 18 months
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Post-treatment clinical course
Number of subjects: 2
Study: 6274563

Group type: EXPERIMENTAL
Intervention: Atenolol (100 mg/kg) after 8 weeks
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo after 4 weeks
Number of subjects: 17
Study: 31556651

Group type: EXPERIMENTAL
Intervention: Family Check-Up (FCU)
Number of subjects: 672
Study: 28641636

Group type: EXPERIMENTAL
Intervention: IMRT
Number of subjects: 63

Group type: COMPARATOR
Intervention: CRT
Number of subjects: 63
Study: 26297084

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral group training
Number of subjects: 162

Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 162
Study: 24306620

Group type: EXPERIMENTAL
Intervention: S SVM based method for prostate volume estimation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Prolate ellipsoid method for prostate volume estimation
Number of subjects: 0
Study: 21983032

Group type: EXPERIMENTAL
Intervention: 1.0 mg/kg MDMA
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 1.6 mg/kg MDMA
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 1.0 mg/kg MDMA and 1.6 mg/kg MDMA
Number of subjects: 10
Study: 19647657

Group type: EXPERIMENTAL
Intervention: Parental presence during emergence from anesthesia
Number of subjects: 0

Group type: COMPARATOR
Intervention: Parental absence during emergence from anesthesia
Number of subjects: 0
Study: 17472226

Group type: EXPERIMENTAL
Intervention: Methylphenidate (MPH)
Number of subjects: 32
Study: 11573514

Group type: EXPERIMENTAL
Intervention: Er:YAG laser irradiation (G 1, 2 Hz and 136‐184 mJ/pulse)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Er:YAG laser irradiation (G 2, 2 Hz and 170‐230 mJ/pulse)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: High energy laser irradiation (G 2)
Number of subjects: 40
Study: 9175950

Group type: EXPERIMENTAL
Intervention: R‐HuEpo (480 U/kg/wk)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study: 1539791

Group type: EXPERIMENTAL
Intervention: Timolol ophthalmic solution 0.25%
Number of subjects: 30

Group type: COMPARATOR
Intervention: Normal saline
Number of subjects: 30
Study: 3886278

Group type: EXPERIMENTAL
Intervention: Balsam of Peru
Number of subjects: 221

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 221

Group type: EXPERIMENTAL
Intervention: Balsam of Peru and Placebo
Number of subjects: 221

Group type: EXPERIMENTAL
Intervention: Dietary restriction of balsams
Number of subjects: 221
Study: 31356475

Group type: EXPERIMENTAL
Intervention: 4% albumin in lactated Ringer's solution
Number of subjects: 360

Group type: COMPARATOR
Intervention: Lactated Ringer's solution alone
Number of subjects: 360
Study: 30646345

Group type: EXPERIMENTAL
Intervention: Residuals cohort
Number of subjects: 1346

Group type: EXPERIMENTAL
Intervention: Gastroenterology care cohort
Number of subjects: 1346

Group type: EXPERIMENTAL
Intervention: ED care cohort
Number of subjects: 1346
Study: 27741005

Group type: EXPERIMENTAL
Intervention: Doppler-guided hemorrhoidal artery ligation (DGHAL)
Number of subjects: 393

Group type: COMPARATOR
Intervention: Circular stapled hemorrhoidopexy (SH)
Number of subjects: 393
Study: 24986373

Group type: EXPERIMENTAL
Intervention: RenalGuard system (automated matched hydration)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Non-matched saline infusion (sham-controlled group)
Number of subjects: 100
Study: 22932715

Group type: EXPERIMENTAL
Intervention: Solitaire Flow Restoration Device
Number of subjects: 113

Group type: COMPARATOR
Intervention: Merci Retrieval System
Number of subjects: 113
Study: 20516538

Group type: EXPERIMENTAL
Intervention: Hydrocortisone acetate (1.5 ml) and hyaluronidase (1500 IU) at weekly interval for 22 weeks
Number of subjects: 100

Group type: COMPARATOR
Intervention: Triamcinolone acetonide (10 mg/ml) and hyaluronidase (1500 IU) at 15 days interval for 22 weeks
Number of subjects: 100
Study: 18485551

Group type: EXPERIMENTAL
Intervention: Eccentric exercise
Number of subjects: 18

Group type: COMPARATOR
Intervention: Concentric exercise
Number of subjects: 18
Study: 15872342

Group type: EXPERIMENTAL
Intervention: Abciximab
Number of subjects: 182

Group type: COMPARATOR
Intervention: Stenting alone
Number of subjects: 182
Study: 14685950

Group type: EXPERIMENTAL
Intervention: Insight: A cognitive enhancement program for women (short-term cognitive group therapy)
Number of subjects: 19
Study: 10232737

Group type: EXPERIMENTAL
Intervention: T cell add-back therapy (up to 3 doses based on risk factors for GVHD)
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: First add-back of T cells
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Second add-back of T cells
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Third add-back of T cells
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Related patients
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Unrelated patients
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Overall GVHD mortality
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Unrelated recipients with larger number of T cells
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Unrelated transplant
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Relapse-free survival of patients with leukemia
Number of subjects: 144
Study: 8909478

Group type: EXPERIMENTAL
Intervention: Parents present with instructions on how to help their children
Number of subjects: 431

Group type: EXPERIMENTAL
Intervention: Parents present without instructions
Number of subjects: 431

Group type: COMPARATOR
Intervention: Parents not present
Number of subjects: 431
Study: 1859744

Group type: EXPERIMENTAL
Intervention: Midazolam 81 (SEM 32) micrograms kg‐1
Number of subjects: 40

Group type: COMPARATOR
Intervention: Propofol 950 (400) micrograms kg‐1
Number of subjects: 40

Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 40
Study: 30414786

Group type: EXPERIMENTAL
Intervention: Low-tension BTB autograft
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: High-tension BTB autograft
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Low-tension HS autograft
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: High-tension HS autograft
Number of subjects: 90

Group type: COMPARATOR
Intervention: HS autograft (both tension groups)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Patient-reported outcomes
Number of subjects: 90
Study: 27186822

Group type: EXPERIMENTAL
Intervention: Subperception spinal cord stimulation at 1 kHz
Number of subjects: 22
Study: 24532276

Group type: EXPERIMENTAL
Intervention: Mean BP ≤130/85 mm Hg
Number of subjects: 91

Group type: COMPARATOR
Intervention: Mean BP >130/85 mm Hg
Number of subjects: 91
Study: 22502623

Group type: EXPERIMENTAL
Intervention: CAM intervention (acupuncture, neural therapy with 1% procaine injection, cupping and bleeding, TCM herbs)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Control group (wait-list, delayed treatment)
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Immediate treatment group
Number of subjects: 59